Shares of Team17 Group plc (LON:TM17 – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is GBX 386.25 ($4.85).
A number of brokerages have recently issued reports on TM17. Citigroup restated a “buy” rating on shares of Team17 Group in a research note on Friday, May 3rd. Barclays boosted their target price on Team17 Group from GBX 265 ($3.33) to GBX 310 ($3.89) and gave the stock an “overweight” rating in a research report on Thursday, April 18th. Jefferies Financial Group restated a “hold” rating and set a GBX 230 ($2.89) price objective on shares of Team17 Group in a report on Friday, April 19th. Shore Capital reaffirmed a “buy” rating on shares of Team17 Group in a research note on Tuesday, April 16th. Finally, Berenberg Bank restated a “buy” rating and set a GBX 490 ($6.16) target price on shares of Team17 Group in a report on Tuesday, April 16th.
View Our Latest Stock Analysis on Team17 Group
Team17 Group Stock Performance
Team17 Group Company Profile
Team17 Group plc, together with its subsidiaries, develops and publishes independent video games for digital and physical market in the United Kingdom and internationally. It operates through Games Label, Simulation, and Edutainment segments. The company develops and publishes owned and third-party IP video games; educational entertainment apps for children; and working simulation games.
Read More
- Five stocks we like better than Team17 Group
- The 3 Best Blue-Chip Stocks to Buy Now
- Garmin Navigates to New Highs Driven By Wearables Trend
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- What Are Trending Stocks? Trending Stocks Explained
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Team17 Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Team17 Group and related companies with MarketBeat.com's FREE daily email newsletter.